Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 27
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
J Appl Microbiol ; 132(6): 4476-4485, 2022 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-35279932

RESUMEN

AIMS: In food animals, Salmonella can exist as multiserovar populations, and the goal of this study was to determine whether Salmonella-positive animal feed samples also consist of multiserovar populations. METHODS AND RESULTS: In all, 50 Salmonella-positive samples, collected from 10 countries, were cultured using three different media for Salmonella isolation: universal pre-enrichment broth, Rappaport-Vassiliadis (RV) broth and tetrathionate (TT) broth. The samples included 25 samples from feed ingredients, 13 from complete feed and 12 feed mill dust samples. Samples from pelleted overnight cultures were analysed by CRISPR-SeroSeq to examine serovar populations in individual samples. Serovars Anatum and Mbandaka were the most commonly identified and were found in feed, feed ingredients and feed environments. Serovars commonly associated with human illness were also identified, and included serovars Enteritidis, Typhimurium and Infantis. Overall, we detected 12 different serogroups (37 different serovars), with eight serovars belonging to the O:7 serogroup (C1 ). Over half (56%) of the samples contained two or more serovars, with 11 serovars found in one sample. Feed ingredients exhibited higher serovar diversity, with an average of three serovars. Across paired samples of pre-enriched and enriched populations, the Bray-Curtis dissimilarity metric showed that 83% of serovar populations were a strong match. CONCLUSIONS: The data presented show that serovars belonging to the O:7 serogroup are commonly found in feed, and that feed can contain multiple serovars. The serovar populations across different Salmonella media were largely concordant. SIGNIFICANCE AND IMPACT OF STUDY: The presence of Salmonella in animal feed is considered a transmission route into meat and poultry products and this study demonstrates that animal feed can contain multiple Salmonella serovars.


Asunto(s)
Salmonelosis Animal , Salmonella , Alimentación Animal , Animales , Medios de Cultivo , Salmonella/genética , Serogrupo
2.
Eur J Obstet Gynecol Reprod Biol ; 269: 90-97, 2022 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-34979364

RESUMEN

OBJECTIVE: Urinary tract infections (UTI) among women form a substantial part of medical practice and both patients and medical professionals have an interest in non-antibiotic treatments and preventative measures. This research provides preliminary data on a multi-functional composition, DAPAD, which explored several biologic activities of relevance to UTI. STUDY DESIGN: This formulation included D-mannose, citric acid, three prebiotic compounds, and extracts of dandelion and astragalus. Studies performed employed 4 bacterial strains that have relevance to UTI including E. coli, Proteus mirabilis, Streptococcus agalactiae and Enterococcus faecalis. RESULTS: Key findings from in vitro studies included: DAPAD at full- and half-strength inhibited growth of all UTI bacteria. Evidence for D-mannose agglutination of E. coli was demonstrated. D-mannose also showed unexpected effects on bacterial membrane integrity with vital staining and modest growth restriction. We did not demonstrate growth inhibition by dandelion or astragalus extracts but the latter showed diminished cytokine elaboration by bladder epithelial cells. CONCLUSION: DAPAD is a multifunctional composition that may warrant further development as a UTI treatment or preventive if supported by clinical evaluation.


Asunto(s)
Escherichia coli , Infecciones Urinarias , Antibacterianos/uso terapéutico , Enterococcus faecalis , Femenino , Humanos , Proteus mirabilis , Infecciones Urinarias/tratamiento farmacológico , Infecciones Urinarias/prevención & control
3.
Pathogens ; 10(12)2021 Dec 03.
Artículo en Inglés | MEDLINE | ID: mdl-34959532

RESUMEN

Many non-prescription preparations intended to treat or alleviate symptoms of vaginal infection are available in American and European markets, but many have scant preclinical or clinical research underpinning. Respecta®Balance Gel (RBG) is marketed as an adjunct to probiotic treatment and its relevant antimicrobial properties were studied. Key findings with the manufacturer-supplied gel showed reduced turbidity in broth-dilution tests by 50% against Candida albicans and Candida glabrata at RBG concentrations 0.2-0.4% of neat product, respectively. A 50% reduction in turbidity of Escherichia coli, Streptococcus agalactiae, Enterococcus faecalis ranged from 1.6-2.2% and Gardnerella vaginalis was shown by flow cytometry counts to undergo a 50% reduction at 0.3% RBG. Propidium iodide staining indicated a rapid reduction of cell integrity of G. vaginalis almost immediately while after 4 h 45% of E. coli cells were stained. The lactic acid in BHI inhibited bacteria and yeast at concentrations ranging from 0.2-1.8% but inhibition was not solely due to pH since a 1:4 dilution of RBG resulted in a pH near neutral (6.75). Other findings showed biofilm accumulation assessed after 10-days exposure of Candida spp. to RBG and was reduced by an average of one-third (community strains) to one-half (drug-resistant strains). One excipient of the RBG, disodium EDTA, inhibited the growth of bacteria and yeast at concentrations below those present in RBG and may accentuate the activity of the host defense factor, lactoferrin. We conclude that RBG is a potent inhibitor of vaginal microorganisms relevant to vaginitis or intrapartum infections and contains excipients that may contribute to its antimicrobial activity.

4.
Pathogens ; 10(3)2021 Mar 03.
Artículo en Inglés | MEDLINE | ID: mdl-33802379

RESUMEN

Candida albicans overgrowth at various mucosal sites is an ongoing and complex clinical concern involving interactions with indigenous microbiota and therapeutic or preventive measures superimposed on the pathogen-microbiome interaction. In this paper we describe the use of quantitative flow cytometry (specific to the cytometer's sample introduction mechanism) to explore the in vitro interaction between Candida albicans, probiotic lactobacilli and a topical vaginal therapeutic. Our central hypothesis was cytometric measurements of co-cultures of yeast and bacteria could provide a useful method for exploring the dynamics of different microbial species in culture, with and without inhibitors. Two commercial products were used as exemplars for this research, a vaginal antimicrobial gel and two species of probiotic lactobacillus intended or oral administration with crystalline bovine lactoferrin to augment the vaginal gel. The cytometer forward channel height parameter distinguished yeast from bacteria in co-culture experiments in the presence of a vaginal therapeutic gel or components of its formulation including EDTA, glycogen, polydextrose as well as the host defense factor, lactoferrin. Flow cytometry showed lactobacilli influenced yeast counts in co-culture, with the technique lending itself to wide-ranging test conditions including organisms, media composition and screening of various antimicrobials. Key findings: The proprietary vaginal gel augmented the effect of lactobacilli, as did EDTA and lactoferrin. Prebiotic compounds also enhanced Candida inhibition by lactobacilli. Propidium iodide (Fluorescence channel 3) discriminated between necrotic and non-necrotic yeast and bacteria in co-cultures under various culture conditions. This research demonstrates the value of flow cytometry to evaluate the population dynamics of yeast and bacteria in co-culture using a proprietary product and its components. We discuss both the limitations of the current study and describe how methods employed here would be transferrable to the investigation of organisms present in defined cultures or at body sites colonized by fungal species and the effects of therapeutics or probiotics on Candida.

5.
BMC Res Notes ; 13(1): 400, 2020 Aug 27.
Artículo en Inglés | MEDLINE | ID: mdl-32854782

RESUMEN

OBJECTIVE: Soft tissue manual therapies are commonly utilized by osteopathic physicians, chiropractors, physical therapists and massage therapists. These techniques are predicated on subjecting tissues to biophysical mechanical stimulation but the cellular and molecular mechanism(s) mediating these effects are poorly understood. Previous studies established an in vitro model system for examining mechanical stimulation of dermal fibroblasts and established that cyclical strain, intended to mimic overuse injury, induces secretion of numerous pro-inflammatory cytokines. Moreover, mechanical strain intended to mimic soft tissue manual therapy reduces strain-induced secretion of pro-inflammatory cytokines. Here, we sought to partially confirm and extend these reports and provide independent corroboration of prior results. RESULTS: Using cultures of primary human dermal fibroblasts, we confirm cyclical mechanical strain increases levels of IL-6 and adding long-duration stretch, intended to mimic therapeutic soft tissue stimulation, after cyclical strain results in lower IL-6 levels. We also extend the prior work, reporting that long-duration stretch results in lower levels of IL-8. Although there are important limitations to this experimental model, these findings provide supportive evidence that therapeutic soft tissue stimulation may reduce levels of pro-inflammatory cytokines. Future work is required to address these open questions and advance the mechanistic understanding of therapeutic soft tissue stimulation.


Asunto(s)
Citocinas , Manipulaciones Musculoesqueléticas , Células Cultivadas , Fibroblastos , Humanos , Piel
7.
Mycopathologia ; 183(2): 349-357, 2018 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-28993976

RESUMEN

Clinical use of boric acid as a topical antifungal in women who have failed standard antifungal therapy with azole drugs has been used sporadically for decades. Our previous in vitro work showing inhibition of Candida albicans growth was conducted on clinical isolates without antifungal drug susceptibility profiling. Here, we report that boric acid restricts growth of drug-resistant Candida albicans and inhibits hyphal growth and diminishes cell volume. The availability of over-the-counter organoboron compounds intended for use as oral nutritional supplements led us to determine if these also were inhibitory toward resistant Candida and show here that they also possess antifungal activity. Candida glabrata was also found to be inhibited by boric acid and organoboron compounds. Further development of organoboron compounds as topical therapeutics is of potential value.


Asunto(s)
Antifúngicos/farmacología , Ácidos Bóricos/farmacología , Compuestos de Boro/farmacología , Candida albicans/efectos de los fármacos , Compuestos Orgánicos/farmacología , Candida albicans/crecimiento & desarrollo , Candida albicans/aislamiento & purificación , Candida glabrata/efectos de los fármacos , Candida glabrata/crecimiento & desarrollo , Candida glabrata/aislamiento & purificación , Candidiasis/microbiología , Femenino , Humanos , Hifa/efectos de los fármacos , Hifa/crecimiento & desarrollo , Pruebas de Sensibilidad Microbiana
10.
Int J Environ Health Res ; 22(4): 305-16, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-22128914

RESUMEN

The object of this study was to quantify vancomycin-resistant enterococci in surface water from Central Iowa obtained from April 2007 to August 2007. Water from established sampling sites in four watersheds was plated on bile-esculin agar. Presumptively identified enterococci were categorized as "above the level of concern" if the sample contained ≥ 107 CFU per 100 ml. Confirmation of isolates as enterococci was based on growth at elevated temperature in high salt and on Enterococcus agar. Isolates that grew on 6 µg/ml vancomycin agar were deemed resistant. PCR analysis of resistant strains characterized vancomycin resistance genes. 77.2% of surface water samples from Central Iowa contained enterococci. Among enterococcal isolates, 10.4% grew on media containing 6 µg/ml vancomycin. PCR analysis of resistance genes showed a preponderance of VanC2/C3 in the area studied and VanB was not detected. Vancomycin-resistant Enterococcus is present in Central Iowa surface waters but resistance rarely involved VanA genotypes. Nevertheless, the potential for community-acquired infections remains a risk.


Asunto(s)
Antibacterianos/farmacología , Enterococcus/efectos de los fármacos , Enterococcus/genética , Ríos/microbiología , Resistencia a la Vancomicina , Vancomicina/farmacología , Proteínas Bacterianas/genética , Ligasas de Carbono-Oxígeno/genética , Enterococcus/clasificación , Enterococcus/aislamiento & purificación , Iowa , Péptido Sintasas/genética , Reacción en Cadena de la Polimerasa , Estaciones del Año
11.
Infect Dis Obstet Gynecol ; 2011: 353297, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-22114461

RESUMEN

The uterine cervix plays a vital role in maintaining pregnancy and an equally important role in allowing parturition to occur. Progesterone, either endogenously produced or supplied exogenously, supports the function of the cervix in sustaining intrauterine pregnancy, and the withdrawal of progesterone, either through natural processes or pharmacologic intervention, leads to delivery which underscores the importance of the progesterone's biological activities manifest in normal gestation and pregnancy that ends prematurely. Research crossing many scientific disciplines has demonstrated that progesterone is a pleotropic compound that affects the cervix through cytoplasmic and membrane receptors with profound effects on cellular and molecular functions that influence inflammatory cascades and extracellular matrix, both of which have consequences for parturition. Beyond the local cell and molecular biology of progesterone, it has systemic effects of relevance to pregnancy as well. This paper examines the biology of the cervix from its gross to cellular structure and biological activities of its cell and molecular processes that may be affected by progesterone. The implications of these processes for preterm birth are explored, and direction of current research is in relation to translational medicine implications for diagnostic, prognostic, and therapeutic approaches to threatened preterm birth.


Asunto(s)
Cuello del Útero/fisiología , Nacimiento Prematuro/fisiopatología , Progesterona/fisiología , Animales , Maduración Cervical/fisiología , Cuello del Útero/anatomía & histología , Citocinas/metabolismo , Epitelio/fisiología , Femenino , Humanos , Inflamación/metabolismo , Embarazo , Nacimiento Prematuro/etiología , Investigación Biomédica Traslacional
12.
Am J Obstet Gynecol ; 204(2): 120.e1-5, 2011 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-20832044

RESUMEN

Ever since the pH of the vagina was found to be much more acidic than blood and interstitial fluids, a belief going back more than a century has persisted that the vagina is protected from pathogenic organisms by the high level of hydronium ions present. A corollary of this belief is that the pH of the vagina and antipathogen activity is due to colonizing Lactobacilli. Unfortunately, this dogma lacks empirical research support. The vaginal pH is determined by the interplay between vaginal physiological processes and microbiology. An acidic vaginal pH and Lactobacilli are components of multiple defense mechanisms active in protection against infection in the lower female genital tract.


Asunto(s)
Lactobacillus/fisiología , Vagina/microbiología , Epitelio/microbiología , Epitelio/fisiología , Femenino , Humanos , Concentración de Iones de Hidrógeno , Vagina/fisiología
13.
Artículo en Inglés | MEDLINE | ID: mdl-20706675

RESUMEN

Recent work on the Molicutes that associate with genital tract tissues focuses on four species that may be of interest in potential maternal, fetal, and neonatal infection and in contributing to adverse pregnancy outcomes. Mycoplasma hominis and Ureaplasma urealyticum have historically been the subject of attention, but Mycoplasma genitalis which causes male urethritis in addition to colonizing the female genital tract and the division of Ureaplasma into two species, urealyticum and parvum, has also added new taxonomic clarity. The role of these genital tract inhabitants in infection during pregnancy and their ability to invade and infect placental and fetal tissue is discussed. In particular, the role of some of these organisms in prematurity may be mechanistically related to their ability to induce inflammatory cytokines, thereby triggering pathways leading to preterm labor. A review of this intensifying exploration of the mycoplasmas in relation to pregnancy yields several questions which will be important to examine in future research.


Asunto(s)
Enfermedades Fetales/microbiología , Infecciones por Mycoplasma/complicaciones , Complicaciones Infecciosas del Embarazo/microbiología , Infecciones por Ureaplasma/complicaciones , Animales , Citocinas/metabolismo , Femenino , Humanos , Recién Nacido , Mycoplasma/patogenicidad , Infecciones por Mycoplasma/epidemiología , Mycoplasma genitalium , Mycoplasma hominis , Trabajo de Parto Prematuro/microbiología , Embarazo , Resultado del Embarazo , Nacimiento Prematuro/microbiología , Ureaplasma , Infecciones por Ureaplasma/epidemiología , Ureaplasma urealyticum
14.
Mycopathologia ; 169(3): 183-91, 2010 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-19876762

RESUMEN

Candida albicans at times resides in the intestinal tract, where it experiences exposure to bile salts suggesting a study of the effects of crude bile salts in the form of sodium choleate (NaCho) on C. albicans growth, expression of virulent phenotypes, and adaptation to physiological challenges in vitro. Growth and phenotype alteration was examined by challenging clinical isolates of C. albicans with a wide range of NaCho concentrations by using conventional microbial physiology methods. Our results showed that (1) NaCho did not inhibit growth of yeast cells, up to 40 mg/ml; (2) NaCho powerfully stimulated the hypha formation; (3) NaCho at 2.5 and 5 mg/ml significantly induced CDR1p and biofilm formation, but these effects decreased at higher NaCho concentrations; (4) loss of cell integrity with exposure to 56 degrees C for 15 min, was exacerbated by increasing levels of NaCho; (5) NaCho protected yeast from hydrogen peroxide damage in a dose-dependent manner; and (6) catalase activity was increased by NaCho exposure.


Asunto(s)
Antifúngicos/farmacología , Candida albicans/efectos de los fármacos , Tracto Gastrointestinal/microbiología , Tracto Gastrointestinal/fisiología , Péptidos y Proteínas de Señalización Intercelular/farmacología , Colato de Sodio/farmacología , Biopelículas/efectos de los fármacos , Biopelículas/crecimiento & desarrollo , Candida albicans/crecimiento & desarrollo , Candida albicans/aislamiento & purificación , Candidiasis/microbiología , Recuento de Colonia Microbiana , Relación Dosis-Respuesta a Droga , Humanos , Hifa/efectos de los fármacos , Hifa/crecimiento & desarrollo , Factores de Tiempo
15.
N Am J Med Sci ; 2(1): 5-10, 2010 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-22624106

RESUMEN

BACKGROUND: Probiotic microorganisms are potential treatments for Clostridium difficile diarrheal disease (CDD) but better methods are needed to determine the relative potency of probiotic microorganisms against pathogenic organisms in mixed cultures. AIM: Quantify C. difficile in the presence of putative probiotic organisms using molecular methods to determine relative probiotic potency. MATERIALS AND METHODS: C. difficile strains were cultivated anaerobically. Serial dilutions of Lactobacillus cultures or microbial mixtures from kefir were co-cultured with C. difficile for 48 hours. Bacterial DNA was extracted and qPCR was used to measure C. difficile toxin A gene, on the basis of cycle threshold (Ct) number. RESULTS: Strains of Lactobacillus (human and ATCC derived), and mixed cultures from commercial kefir were co-cultured with C. difficile. Lactobacillus and the microbial mixture from kefir were ranked in order of their potency in C. difficile growth inhibition. CONCLUSIONS: PCR allows facile quantification of C. difficle in the presence of other. The technique measures relative potency of over-the-counter probiotics and may predict human strains meriting probiotic status.

17.
J Antimicrob Chemother ; 63(2): 325-36, 2009 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-19059942

RESUMEN

BACKGROUND: Boric acid is a commonly cited treatment for recurrent and resistant yeast vaginitis, but data about the extent and mechanism of its antifungal activity are lacking. OBJECTIVES: The aim of this study was to use in vitro methods to understand the spectrum and mechanism of boric acid as a potential treatment for vaginal infection. METHODS: Yeast and bacterial isolates were tested by agar dilution to determine the intrinsic antimicrobial activity of boric acid. Established microbial physiology methods illuminated the mechanism of the action of boric acid against Candida albicans. RESULTS: C. albicans strains (including fluconazole-resistant strains) were inhibited at concentrations attainable intravaginally; as were bacteria. Broth dilution MICs were between 1563 and 6250 mg/L and boric acid proved fungistatic (also reflected by a decrease in CO(2) generation); prolonged culture at 50,000 mg/L was fungicidal. Several organic acids in yeast nitrogen broth yielded a lower pH than equimolar boric acid and sodium borate but were less inhibitory. Cold or anaerobic incubation protected yeast at high boric acid concentrations. Cells maintained integrity for 6 h in boric acid at 37 degrees C, but after 24 h modest intrusion of propidium iodide occurred; loss of plate count viability preceded uptake of vital stain. Growth at sub-MIC concentrations of boric acid decreased cellular ergosterol. The drug efflux pump CDR1 did not protect Candida as CDR1 expression was abrogated by boric acid. Boric acid interfered with the development of biofilm and hyphal transformation. CONCLUSIONS: Boric acid is fungistatic to fungicidal depending on concentration and temperature. Inhibition of oxidative metabolism appears to be a key antifungal mechanism, but inhibition of virulence probably contributes to therapeutic efficacy in vivo.


Asunto(s)
Antifúngicos/farmacología , Ácidos Bóricos/farmacología , Candida albicans/efectos de los fármacos , Bacterias/efectos de los fármacos , Candida albicans/química , Candidiasis Vulvovaginal/tratamiento farmacológico , Recuento de Colonia Microbiana , Ergosterol/análisis , Femenino , Humanos , Pruebas de Sensibilidad Microbiana , Viabilidad Microbiana
18.
Infect Dis Obstet Gynecol ; 2008: 493508, 2008.
Artículo en Inglés | MEDLINE | ID: mdl-18528520

RESUMEN

OBJECT: To determine if tetracycline, previously reported to increase the probability of developing symptomatic vaginal yeast infections, has a direct effect on Candida albicans growth or induction of virulent phenotypes. METHOD: In vitro, clinical isolates of yeast were cultivated with sublethal concentrations of tetracycline and yeast cell counts, hyphal formation, drug efflux pump activity, biofilm production, and hemolysin production were determined by previously reported methods. RESULTS: Tetracycline concentrations above 150 microg/mL inhibited Candida albicans, but at submicrogram/mL, a modest growth increase during the early hours of the growth curve was observed. Tetracycline did not inhibit hyphal formation at sublethal concentrations. Hypha formation appeared augmented by exposure to tetracycline in the presence of chemically defined medium and especially in the presence of human serum. Efflux pump CDR1 was upregulated and a nonsignificant trend toward increased biofilm formation was noted. CONCLUSION: Tetracycline appears to have a small growth enhancing effect and may influence virulence through augmentation of hypha formation, and a modest effect on drug efflux and biofilm formation, although tetracycline did not affect hemolysin. It is not clear if the magnitude of the effect is sufficient to attribute vaginitis following tetracycline treatment to direct action of tetracycline on yeast.


Asunto(s)
Antibacterianos/farmacología , Candida albicans/efectos de los fármacos , Candida albicans/patogenicidad , Tetraciclina/farmacología , Factores de Virulencia/metabolismo , Biopelículas/crecimiento & desarrollo , Candida albicans/crecimiento & desarrollo , Medios de Cultivo , Femenino , Proteínas Fúngicas/efectos de los fármacos , Proteínas Fúngicas/metabolismo , Proteínas Hemolisinas/metabolismo , Humanos , Hifa/efectos de los fármacos , Hifa/crecimiento & desarrollo , Proteínas de Transporte de Membrana/efectos de los fármacos , Proteínas de Transporte de Membrana/metabolismo , Regulación hacia Arriba
19.
Environ Toxicol Chem ; 27(11): 2346-51, 2008 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-18476751

RESUMEN

The ubiquitous yeast Candida albicans becomes a troublesome pathogen by inducing virulence factors in response to environmental stimuli. Among these virulence factors is a drug-exporting transport protein, Cdrlp, which renders cells resistant to certain antifungal drugs. The expression of the CDR1 gene responds to a wide spectrum of stimuli, including drugs, heat shock, and steroid hormones. The aim of the present study is to characterize the effects of commonly used herbicides on the expression of CDR1. Following exposure of C. albicans cultures to varying doses of herbicides and azole drugs, CDR1 expression was quantified by flow cytometry using a reporter strain in which expression of a green fluorescent protein is under the control of the CDR1 promoter. Correlating CDR1 expression with cell growth and survival revealed that-similar to antifungal azole drugs-herbicides induce CDR1 expression only at inhibitory doses. It is concluded that none of the tested herbicides mimics the worrisome action of hormones, which increase virulence without reducing survival.


Asunto(s)
Antifúngicos/farmacología , Candida albicans/efectos de los fármacos , Proteínas Fúngicas/biosíntesis , Proteínas de Transporte de Membrana/biosíntesis , Candida albicans/patogenicidad , Clotrimazol/farmacología , Fluconazol/farmacología , Proteínas Fúngicas/genética , Cetoconazol/farmacología , Proteínas de Transporte de Membrana/genética
20.
Yeast ; 23(11): 795-802, 2006 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-16921553

RESUMEN

The Candida albicans CDR1 gene, encoding an ABC transporter that functions as an efflux pump, is thought to be involved in pathogenic adaptation and uses mammalian hormones and other environmental cues to regulate its activity. Exposure of several clinical isolates of C. albicans to 1 x 10(-8) M 17beta-oestradiol increased CDR1 expression and the isolates showed a positive correlation between oestrogen induction of CDR1 and growth in the presence of oestrogen. A reporter strain carrying the GFP gene under the control of the CDR1 promoter was used to analyse the effect of steroid hormones and antifungal drugs on CDR1 expression by flow cytometry. We found that among the many hormones tested, only oestradiol and progesterone induce CDR1 expression. CDR1 induction requires hormone concentrations greater than 10(-8) M, a threshold reached in vivo only by progesterone. Using the GFP-reporter strain, we show CDR1 induction by female but not male human serum and demonstrate that exposure of C. albicans to physiological concentrations of progesterone measurably increases resistance to fluconazole, miconazole and 5-fluorouracil. Simultaneous exposure of C. albicans to hormones and antifungal drugs provided evidence that both agents induce CDR1 expression via different mechanisms with different saturation points.


Asunto(s)
Antifúngicos/farmacología , Candida albicans/efectos de los fármacos , Candida albicans/metabolismo , Estradiol/farmacología , Proteínas Fúngicas/biosíntesis , Proteínas de Transporte de Membrana/biosíntesis , Progesterona/farmacología , Candida albicans/genética , Candida albicans/aislamiento & purificación , Farmacorresistencia Fúngica , Femenino , Citometría de Flujo/métodos , Proteínas Fúngicas/genética , Proteínas Fúngicas/metabolismo , Proteínas Fluorescentes Verdes/genética , Proteínas Fluorescentes Verdes/metabolismo , Humanos , Masculino , Proteínas de Transporte de Membrana/genética , Proteínas de Transporte de Membrana/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...